$AVR News
Last published 2d ago
- 2d agoAVRAnteris Technologies Announces Results for the Third Quarter of 2026GlobeNewswire
- 1w agoAVRAnteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026GlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Nov. 01, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) a global healthcare company committed to
- 2w agoAVRAnteris Announces Upcoming Data Release for Medium-Size DurAVR THV from EMBARK Study at TCT 2026GlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) today announced that Azeem Latib, MD, will
- 3w agoAVRAnteris Advances Global PARADIGM Trial Expansion with German Regulatory ClearanceGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) announced today that it has received full
- 2mo agoAVRAnteris to Present at September Healthcare Investor ConferencesGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) a global healthcare company committed to
- 3mo agoAVRAnteris Technologies Announces Results for the Second Quarter of 2026GlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) a global healthcare company committed to
- 5mo agoAVRAnteris Advances Global PARADIGM Expansion with French Regulatory ClearanceGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, June 08, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) announced today that it has received full regulatory
- 6mo agoAVRAnteris Appoints Susan Knight and Stephen Denaro to its Board of DirectorsGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, May 13, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 6mo agoAVRAnteris Announces Results for the First Quarter of 2026GlobeNewswireMINNEAPOLIS and BRISBANE, Australia, May 12, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 6mo agoAVRAnteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM TrialGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, May 05, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)), a global structural heart company committed to designing,
- 6mo agoAVRAnteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM TrialGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, April 28, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)), a global structural heart company committed to designing,
- 8mo agoAVRAnteris Reports 2025 Financial Results and Provides Corporate UpdateGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)), a global structural heart company committed to designing,
- 8mo agoAVRAnteris to Present at Healthcare Investor Conferences TD Cowen and BarclaysGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 9mo agoAVRMDTAnteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital RaisesGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 9mo agoAVRAnteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common StockGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)), a global structural heart company committed to designing,
- 9mo agoAVRAnteris Technologies Global Corp. Announces Pricing of $200 Million Public OfferingGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)), a global structural heart company committed to designing,
- 9mo agoAVRAnteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from MedtronicGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)), a global structural heart company committed to designing,
- 12mo agoAVRAnteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London ValvesGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) today released 30-day clinical outcomes for the DurAVR® THV
- 1y agoAVRAnteris Announces Results for the Third Quarter of 2025GlobeNewswireMINNEAPOLIS, Minn. and BRISBANE, Australia , Nov. 12, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to
- 1y agoAVRFDA Approves Anteris's DurAVR® THV Global Pivotal Trial (the "PARADIGM Trial")GlobeNewswirePARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR® bIomimetic valve designed for physioloGic flow compared to CoMmercial TAVR devices MINNEAPOLIS and BRISBANE,
- 1y agoAVRAnteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One YearGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 1y agoAVRAnteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the "PARADIGM Trial")GlobeNewswireMINNEAPOLIS, United States and BRISBANE, Australia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to
- 1y agoAVRAnteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025GlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)), a global structural heart company committed to designing,
- 1y agoAVRAnteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the "PARADIGM Trial")GlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 1y agoAVRAnteris Technologies Global Corp. Announces Adjournment of Special Meeting of StockholdersGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)), a global structural heart company committed to designing,
- 1y agoAVRAnteris Technologies Global Corp. Announces Postponement of Special Meeting of StockholdersGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)), a global structural heart company committed to designing,
- 1y agoAVRAnteris Technologies Global Corp. Announces Postponement of Special Meeting of StockholdersGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)), a global structural heart company committed to designing,
- 1y agoAVRAnteris Announces Results for the Second Quarter of 2025GlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 1y agoAVRLMATAnteris Appoints David Roberts and Gregory Moss to its Board of DirectorsGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, June 09, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 1y agoAVRAnteris Announces Results for the First Quarter of 2025GlobeNewswireMINNEAPOLIS and BRISBANE, Australia, May 13, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 1y agoAVRAnteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THVGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, March 31, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris® or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 1y agoAVRAnteris Reports One-Year Patient Outcomes for DurAVR® THVGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, March 21, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris® or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 1y agoAVRAnteris Reports 2024 Financial Results and Provides Corporate UpdateGlobeNewswireEAGAN, Minn. and BRISBANE, Australia, March 12, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a global structural heart company committed to designing,
- 1y agoAVRAnteris to Present at Healthcare Investor Conferences - TD Cowen and BarclaysGlobeNewswireMINNEAPOLIS and BRISBANE, Australia, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Anteris® Technologies Global Corp. (Anteris or the Company) (NASDAQ:AVR, ASX: AVR)) a structural heart company developing DurAVR® THV, a
- 1y agoAVRAnteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public OfferingBusiness WireAnteris Technologies Global Corp. ("ATGC" or "Anteris") is pleased to announce the closing of its initial public offering of 14,800,000 shares of its common stock (the "Common Stock") in the U.S. at a price of $6.00 per